{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:41:00Z","timestamp":1769636460434,"version":"3.49.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.autrev.2016.06.001","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T12:06:57Z","timestamp":1465646817000},"page":"820-832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Detection of novel diagnostic antibodies in ankylosing spondylitis: An overview"],"prefix":"10.1016","volume":"15","author":[{"given":"Dana H.F.","family":"Quaden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth M.","family":"De Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerle","family":"Somers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0005","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/annrheumdis-2013-204835","article-title":"Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis","volume":"74","author":"Cortes","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2016.06.001_bb0010","doi-asserted-by":"crossref","first-page":"896","DOI":"10.7326\/0003-4819-136-12-200206180-00011","article-title":"Update on spondyloarthropathies","volume":"136","author":"Khan","year":"2002","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0015","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0020","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/annrheumdis-2014-205253","article-title":"The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2016.06.001_bb0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.berh.2006.02.001","article-title":"Concepts and epidemiology of spondyloarthritis","volume":"20","author":"Sieper","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","article-title":"Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis","volume":"23","author":"Feldtkeller","year":"2003","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0040","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.20990","article-title":"The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?","volume":"52","author":"Rudwaleit","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2016.06.001_bb0045","first-page":"1953","article-title":"Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study","volume":"26","author":"Oostveen","year":"1999","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0050","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0055","first-page":"5","article-title":"The challenge of early diagnosis in ankylosing spondylitis","volume":"34","author":"O'Shea","year":"2007","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0060","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","article-title":"Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial","volume":"52","author":"Wanders","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0065","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","article-title":"2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis","volume":"70","author":"van der Heijde","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0070","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/art.23606","article-title":"Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two","volume":"58","author":"Haibel","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0075","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/art.24408","article-title":"Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis","volume":"60","author":"Barkham","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0080","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/ard.2010.139667","article-title":"Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial","volume":"70","author":"Song","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0085","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/rheumatology\/36.7.766","article-title":"The outcome of ankylosing spondylitis: a study of 100 patients","volume":"36","author":"Gran","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/ard.60.4.353","article-title":"Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients","volume":"60","author":"Boonen","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2016.06.001_bb0095","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/ard.60.11.1033","article-title":"Withdrawal from labour force due to work disability in patients with ankylosing spondylitis","volume":"60","author":"Boonen","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"6 Suppl 28","key":"10.1016\/j.autrev.2016.06.001_bb0100","first-page":"S23","article-title":"Socioeconomic consequences of ankylosing spondylitis","volume":"20","author":"Boonen","year":"2002","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2016.06.001_bb0105","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ncprheum0297","article-title":"A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitis","volume":"2","author":"Boonen","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2016.06.001_bb0110","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.1780401015","article-title":"Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment","volume":"40","author":"Brown","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2016.06.001_bb0115","first-page":"763","article-title":"Ankylosing spondylitis: field in progress","volume":"14","author":"Slobodin","year":"2012","journal-title":"Israel Med Assoc J"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/BOR.0b013e3283534df4","article-title":"Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory?","volume":"24","author":"Ambarus","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"8872","key":"10.1016\/j.autrev.2016.06.001_bb0125","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0140-6736(93)91760-J","article-title":"HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis","volume":"342","author":"Hermann","year":"1993","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.autrev.2016.06.001_bb0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","article-title":"HLA-B27","volume":"33","author":"Bowness","year":"2015","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0135","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4049\/jimmunol.170.2.1099","article-title":"CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats","volume":"170","author":"May","year":"2003","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0140","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/art.24599","article-title":"Spondylarthritis in HLA-B27\/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8","volume":"60","author":"Taurog","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"26","key":"10.1016\/j.autrev.2016.06.001_bb0145","doi-asserted-by":"crossref","first-page":"23459","DOI":"10.1074\/jbc.M110336200","article-title":"HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum","volume":"277","author":"Dangoria","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2016.06.001_bb0150","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4419-0298-6_21","article-title":"The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis","volume":"649","author":"Kollnberger","year":"2009","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0155","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.amjmed.2005.01.001","article-title":"Spondyloarthritis: update on pathogenesis and management","volume":"118","author":"Reveille","year":"2005","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0160","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/eji.200635997","article-title":"Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide","volume":"37","author":"Kollnberger","year":"2007","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2016.06.001_bb0165","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/eji.200323678","article-title":"Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling","volume":"33","author":"Bird","year":"2003","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0170","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.4049\/jimmunol.175.4.2438","article-title":"HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response","volume":"175","author":"Turner","year":"2005","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"9","key":"10.1016\/j.autrev.2016.06.001_bb0175","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.24763","article-title":"HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats","volume":"60","author":"DeLay","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.0105-2896.2009.00865.x","article-title":"From HLA-B27 to spondyloarthritis: a journey through the ER","volume":"233","author":"Colbert","year":"2010","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0185","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.semarthrit.2004.08.005","article-title":"Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis","volume":"34","author":"Davis","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0190","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.autrev.2016.06.001_bb0195","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2012-202925","article-title":"Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation","volume":"73","author":"Ciccia","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2016.06.001_bb0200","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/annrheumdis-2013-204170","article-title":"No evidence for a critical role of the unfolded protein response in synovium and blood of patients with ankylosing spondylitis","volume":"73","author":"Neerinckx","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2013.07.013","article-title":"HLA-B27 misfolding and ankylosing spondylitis","volume":"57","author":"Colbert","year":"2014","journal-title":"Mol Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2016.06.001_bb0210","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/rheumatology\/41.12.1375","article-title":"Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease","volume":"41","author":"Cauli","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"9783","key":"10.1016\/j.autrev.2016.06.001_bb0215","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","article-title":"Spondyloarthritis","volume":"377","author":"Dougados","year":"2011","journal-title":"Lancet (London, England)"},{"issue":"12","key":"10.1016\/j.autrev.2016.06.001_bb0220","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.3899\/jrheum.100891","article-title":"Epidemiology of ankylosing spondylitis: IGAS 2009","volume":"37","author":"Reveille","year":"2010","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2016.06.001_bb0225","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ng.2007.17","article-title":"Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants","volume":"39","author":"Burton","year":"2007","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0230","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11882-014-0489-6","article-title":"Update on ankylosing spondylitis: current concepts in pathogenesis","volume":"15","author":"Smith","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0235","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci","volume":"45","author":"Cortes","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.autrev.2016.06.001_bb0240","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/annrheumdis-2012-202135","article-title":"Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model","volume":"72","author":"Van Praet","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2 Pt 1","key":"10.1016\/j.autrev.2016.06.001_bb0245","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0016-5085(89)91557-6","article-title":"Ileocolonoscopy in seronegative spondylarthropathy","volume":"96","author":"De Vos","year":"1989","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.autrev.2016.06.001_bb0250","first-page":"1658","article-title":"HLA antigens in ankylosing spondylitis associated with Crohn's disease. Increased frequency of the HLA phenotype B27,B44","volume":"15","author":"Purrmann","year":"1988","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0255","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/art.20336","article-title":"Enhanced intracellular replication of Salmonella enteritidis in HLA-B27-expressing human monocytic cells: dependency on glutamic acid at position 45 in the B pocket of HLA-B27","volume":"50","author":"Penttinen","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0260","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/art.20211","article-title":"Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy","volume":"50","author":"Hacquard-Bouder","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"9573","key":"10.1016\/j.autrev.2016.06.001_bb0265","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","article-title":"Inflammatory bowel disease: cause and immunobiology","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet (London, England)"},{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0270","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/rheumatology\/33.7.644","article-title":"Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives","volume":"33","author":"Martinez-Gonzalez","year":"1994","journal-title":"Br J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0275","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.berh.2004.05.008","article-title":"Reactive arthritis","volume":"18","author":"Toivanen","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0280","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1084\/jem.180.6.2359","article-title":"The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats","volume":"180","author":"Taurog","year":"1994","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.autrev.2016.06.001_bb0285","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.1128\/IAI.72.12.7183-7189.2004","article-title":"Synovial fibroblasts infected with Salmonella enterica serovar Typhimurium mediate osteoclast differentiation and activation","volume":"72","author":"Zhang","year":"2004","journal-title":"Infect Immun"},{"issue":"9134","key":"10.1016\/j.autrev.2016.06.001_bb0290","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(97)12004-9","article-title":"Classification of inflammatory arthritis by enthesitis","volume":"352","author":"McGonagle","year":"1998","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0295","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","article-title":"Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells","volume":"73","author":"Jacques","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"15","key":"10.1016\/j.autrev.2016.06.001_bb0300","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.febslet.2011.06.019","article-title":"Sost down-regulation by mechanical strain in human osteoblastic cells involves PGE2 signaling via EP4","volume":"585","author":"Galea","year":"2011","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0305","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bone.2011.10.025","article-title":"Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading","volume":"50","author":"Tu","year":"2012","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0310","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-gammat+CD3+CD4\u2212CD8\u2212 entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0315","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","article-title":"Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis","volume":"30","author":"Mei","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0320","first-page":"621","article-title":"Elevated serum interleukin-23 levels in ankylosing spondylitis patients and the relationship with disease activity","volume":"77","author":"Ugur","year":"2015","journal-title":"Nagoya J Med Sci"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0325","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.37937","article-title":"In situ analysis of interleukin-23- and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis","volume":"65","author":"Appel","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0330","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11926-013-0342-2","article-title":"Osteoimmunology and bone homeostasis: relevance to spondyloarthritis","volume":"15","author":"Goldring","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"10.1016\/j.autrev.2016.06.001_bb0335","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jbspin.2012.08.004","article-title":"Common bone turnover markers in rheumatoid arthritis and ankylosing spondylitis: a literature review","volume":"80","author":"Coiffier","year":"2013","journal-title":"Joint Bone Spine Rev Rhum"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0340","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.27231","article-title":"Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis","volume":"62","author":"Daoussis","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0345","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI23738","article-title":"Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis","volume":"115","author":"Lories","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0350","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1186\/ar4096","article-title":"Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors","volume":"14","author":"Haynes","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.06.001_bb0355","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13075-015-0675-5","article-title":"Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS","volume":"17","author":"Bleil","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.autrev.2016.06.001_bb0360","first-page":"2205","article-title":"Osteoporosis, body composition, and bone turnover in ankylosing spondylitis","volume":"26","author":"El Maghraoui","year":"1999","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0365","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3899\/jrheum.100851","article-title":"Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis","volume":"38","author":"Montala","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.06.001_bb0370","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13075-015-0809-9","article-title":"The prevalence of vertebral fractures in spondyloarthritis: relation to disease characteristics, bone mineral density, syndesmophytes and history of back pain and trauma","volume":"17","author":"Geusens","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.autrev.2016.06.001_bb0375","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1136\/ard.2008.092494","article-title":"Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis","volume":"68","author":"Neidhart","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0380","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/art.38404","article-title":"Histomorphologic and histomorphometric characteristics of zygapophyseal joint remodeling in ankylosing spondylitis","volume":"66","author":"Bleil","year":"2014","journal-title":"Arthritis Rheum (Hoboken, NJ)"},{"key":"10.1016\/j.autrev.2016.06.001_bb0385","doi-asserted-by":"crossref","DOI":"10.6064\/2012\/215308","article-title":"B cell in autoimmune diseases","volume":"2012","author":"Hampe","year":"2012","journal-title":"Scientifica"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0390","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/ard.35.2.155","article-title":"Immunological reactivity in ankylosing spondylitis. Circulating immunoblasts, autoantibodies, and immunoglobulins","volume":"35","author":"Eghtedari","year":"1976","journal-title":"Ann Rheum Dis"},{"issue":"15","key":"10.1016\/j.autrev.2016.06.001_bb0395","first-page":"1784","article-title":"Value of the peripheral blood B-cells subsets in patients with ankylosing spondylitis","volume":"122","author":"Lin","year":"2009","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0400","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/ard.41.6.579","article-title":"Histopathology of the synovial membrane of peripheral joints in ankylosing spondylitis","volume":"41","author":"Revell","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.06.001_bb0405","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4939-3335-8_16","article-title":"Toll-like receptor-dependent immune complex activation of B cells and dendritic cells","volume":"1390","author":"Moody","year":"2016","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0410","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1074-7613(04)00112-8","article-title":"Pathogenic roles of B cells in human autoimmunity; insights from the clinic","volume":"20","author":"Martin","year":"2004","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0415","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrd2085","article-title":"B cells move to centre stage: novel opportunities for autoimmune disease treatment","volume":"5","author":"Browning","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0420","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.27383","article-title":"Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial","volume":"62","author":"Song","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.06.001_bb0425","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1038\/ncomms7637","article-title":"Immune complexes regulate bone metabolism through FcRgamma signalling","volume":"6","author":"Negishi-Koga","year":"2015","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0430","first-page":"620","article-title":"Receptor activator of nuclear factor kappa B ligand-mediated osteoclastogenesis is elevated in ankylosing spondylitis","volume":"27","author":"Im","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0435","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/art.21537","article-title":"Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis","volume":"54","author":"Wong","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2016.06.001_bb0440","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1136\/ard.2011.153312","article-title":"Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis","volume":"70","author":"Yeo","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.autrev.2016.06.001_bb0445","first-page":"17362","article-title":"Elevated serum levels of IL-6 and IL-17 may associate with the development of ankylosing spondylitis","volume":"8","author":"Liu","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.autrev.2016.06.001_bb0450","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1600-065X.1999.tb01372.x","article-title":"Fc receptor signaling and trafficking: a connection for antigen processing","volume":"172","author":"Amigorena","year":"1999","journal-title":"Immunol Rev"},{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0455","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur J Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2016.06.001_bb0460","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/annrheumdis-2012-202264","article-title":"The novel cytokine interleukin-36alpha is expressed in psoriatic and rheumatoid arthritis synovium","volume":"72","author":"Frey","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0465","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/35100573","article-title":"From T to B and back again: positive feedback in systemic autoimmune disease","volume":"1","author":"Shlomchik","year":"2001","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0470","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.174.6.3781","article-title":"Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis","volume":"174","author":"O'Neill","year":"2005","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"8","key":"10.1016\/j.autrev.2016.06.001_bb0475","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.4049\/jimmunol.167.8.4710","article-title":"T cell activation in rheumatoid synovium is B cell dependent","volume":"167","author":"Takemura","year":"2001","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.autrev.2016.06.001_bb0480","doi-asserted-by":"crossref","first-page":"316421","DOI":"10.1155\/2015\/316421","article-title":"Ectopic germinal centers and IgG4-producing plasmacytes observed in synovia of HLA-B27+ ankylosing spondylitis patients with advanced hip involvement","volume":"2015","author":"Feng","year":"2015","journal-title":"Int J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0485","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/1529-0131(199801)41:1<180::AID-ART24>3.0.CO;2-V","article-title":"Immunohistologic analysis of peripheral joint disease in ankylosing spondylitis","volume":"41","author":"Cunnane","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2016.06.001_bb0490","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0495","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.berh.2010.05.009","article-title":"Soluble and tissue biomarkers in ankylosing spondylitis","volume":"24","author":"de Vlam","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2016.06.001_bb0500","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/1756-185X.12779","article-title":"The ongoing quest for biomarkers in ankylosing spondylitis","volume":"18","author":"Danve","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2016.06.001_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2016.02.002","article-title":"An update on biomarkers in axial spondyloarthritis","author":"Prajzlerova","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0510","first-page":"1073","article-title":"Clinical utility of common serum rheumatologic tests","volume":"65","author":"Lane","year":"2002","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.autrev.2016.06.001_bb0515","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/rheumatology\/kep393","article-title":"Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs\/coxibs' treatment effect on C-reactive protein","volume":"49","author":"Benhamou","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0520","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/art.33465","article-title":"Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis","volume":"64","author":"Poddubnyy","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0525","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/ard.2007.071605","article-title":"Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab","volume":"67","author":"Visvanathan","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2016.06.001_bb0530","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.24838","article-title":"Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid A protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis","volume":"61","author":"de Vries","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0535","first-page":"980","article-title":"Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis","volume":"26","author":"Spoorenberg","year":"1999","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0540","first-page":"966","article-title":"Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review","volume":"26","author":"Ruof","year":"1999","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0545","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/ard.37.2.146","article-title":"Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease","volume":"37","author":"Ebringer","year":"1978","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2016.06.001_bb0550","first-page":"472","article-title":"Bacterial antibodies in ankylosing spondylitis","volume":"84","author":"Maki-Ikola","year":"1991","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2016.06.001_bb0555","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.54.8.631","article-title":"IgA1 and IgA2 subclass antibodies against Klebsiella pneumoniae in the sera of patients with peripheral and axial types of ankylosing spondylitis","volume":"54","author":"Maki-Ikola","year":"1995","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0560","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/rheumatology\/35.2.125","article-title":"Similarly increased serum IgA1 and IgA2 subclass antibody levels against Klebsiella pneumoniae bacteria in ankylosing spondylitis patients with\/without extra-articular features","volume":"35","author":"Maki-Ikola","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2016.06.001_bb0565","first-page":"1756","article-title":"Antibody response to Klebsiella pneumoniae 60kDa protein in familial and sporadic ankylosing spondylitis: role of HLA-B27 and characterization as a GroEL-like protein","volume":"25","author":"Cancino-Diaz","year":"1998","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0570","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/rheumatology\/36.4.491","article-title":"Antibodies against bacterial lipopolysaccharides in Japanese patients with ankylosing spondylitis","volume":"36","author":"Tani","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2016.06.001_bb0575","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/03009748709165278","article-title":"Enterobacteria and ankylosing spondylitis","volume":"16","author":"Alvaro-Gracia","year":"1987","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0580","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.rhu.0000200374.14619.f2","article-title":"The potential use of antibacterial peptide antibody indices in the diagnosis of rheumatoid arthritis and ankylosing spondylitis","volume":"12","author":"Rashid","year":"2006","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0585","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10067-002-0668-z","article-title":"Antibodies to ubiquitin in relation to Yersinia infection status in patients with ankylosing spondylitis","volume":"22","author":"Hrycaj","year":"2003","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0590","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000080081","article-title":"Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA","volume":"70","author":"Torok","year":"2004","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0595","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/rheumatology\/kem324","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: a reassessment","volume":"47","author":"Aydin","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0600","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00296-010-1722-9","article-title":"Anti-Saccharomyces cerevisiae (ASCA) and anti-endomysial antibodies in spondyloarthritis","volume":"32","author":"Andretta","year":"2012","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0605","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/ard.62.5.455","article-title":"Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy","volume":"62","author":"Hoffman","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0610","first-page":"920","article-title":"Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis","volume":"31","author":"Riente","year":"2004","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0615","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00296-014-3088-x","article-title":"An investigation into the relationship between anti-Helicobacter pylori and anti-Saccharomyces cerevisiae antibodies in patients with axial spondyloarthritis and Crohn disease","volume":"35","author":"Rodrigues","year":"2015","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0620","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4103\/0019-5359.26605","article-title":"Seroprevalance of toxocara antibodies in multiple sclerosis and ankylosing spondylitis","volume":"60","author":"Kuk","year":"2006","journal-title":"Indian J Med Sci"},{"issue":"3","key":"10.1016\/j.autrev.2016.06.001_bb0625","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3341\/kjo.2014.28.3.207","article-title":"Isolation of IgG antibodies to Toxocara in ankylosing spondylitis patients with acute anterior uveitis","volume":"28","author":"Jimenez-Balderas","year":"2014","journal-title":"Korean J Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0630","doi-asserted-by":"crossref","first-page":"R177","DOI":"10.1186\/ar2866","article-title":"Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study","volume":"11","author":"Mundwiler","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0635","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar4350","article-title":"Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study","volume":"15","author":"Wallis","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0640","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-007-8022-5","article-title":"Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets?","volume":"34","author":"Szekanecz","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0645","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0049-0172(96)80043-6","article-title":"Anti-heat-shock protein antibodies in rheumatic and autoimmune diseases","volume":"26","author":"Tishler","year":"1996","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0650","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/rheumatology\/29.6.426","article-title":"Specific antibody response to the mycobacterial 65kDa stress protein in ankylosing spondylitis and rheumatoid arthritis","volume":"29","author":"McLean","year":"1990","journal-title":"Br J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0655","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jbspin.2011.03.010","article-title":"Anti-mutated citrullinated vimentin (anti-MCV) and anti-65kDa heat shock protein (anti-hsp65): new biomarkers in ankylosing spondylitis","volume":"79","author":"Bodnar","year":"2012","journal-title":"Joint Bone Spine Revue Rhum"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0660","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/art.37843","article-title":"Circulating citrullinated vimentin fragments reflect disease burden in ankylosing spondylitis and have prognostic capacity for radiographic progression","volume":"65","author":"Bay-Jensen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0665","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jbspin.2012.10.002","article-title":"The relationship between peripheral arthritis and anti-cyclic citrullinated peptide antibodies in ankylosing spondylitis","volume":"80","author":"Kim","year":"2013","journal-title":"Joint Bone Spine Revue Rhum"},{"issue":"8","key":"10.1016\/j.autrev.2016.06.001_bb0670","first-page":"1476","article-title":"Anti-cyclic citrullinated peptide versus anti-Sa antibodies in diagnosis of rheumatoid arthritis in an outpatient clinic for connective tissue disease and spondyloarthritis","volume":"33","author":"Lopez-Longo","year":"2006","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2016.06.001_bb0675","first-page":"1650","article-title":"Detection of high levels of 2 specific isoforms of 14-3-3 proteins in synovial fluid from patients with joint inflammation","volume":"34","author":"Kilani","year":"2007","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2016.06.001_bb0680","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.3899\/jrheum.131446","article-title":"Serum 14-3-3eta is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis","volume":"41","author":"Maksymowych","year":"2014","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2016.06.001_bb0685","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3899\/jrheum.141385","article-title":"14-3-3eta autoantibodies: diagnostic use in early rheumatoid arthritis","volume":"42","author":"Maksymowych","year":"2015","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2016.06.001_bb0690","first-page":"S1305","article-title":"Autoantibodies to 14-3-3\u03b7 are novel biomarkers associated with inflammation and radiographic progression in ankylosing spondylitis","volume":"66","author":"Maksymowych","year":"2014","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0695","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2010.10.003","article-title":"Novel autoantibody markers for early and seronegative rheumatoid arthritis","volume":"36","author":"Somers","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2016.06.001_bb0700","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kew198","article-title":"Autoantibodies to two novel peptides in seronegative and early rheumatoid arthritis","author":"De Winter","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2016.06.001_bb0705","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.0954-6820.1966.tb05457.x","article-title":"Leucocyte-specific anti-nuclear factors in patients with felty's syndrome, rheumatoid arthritis, systemic lupus erythematosus and other diseases","volume":"179","author":"Faber","year":"1966","journal-title":"Acta Med Scand"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0710","first-page":"158","article-title":"Increased frequency of leukocyte-reactive antinuclear antibody in patients with ankylosing spondylitis","volume":"4","author":"Vasey","year":"1977","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0715","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/ard.38.6.526","article-title":"Antinuclear antibodies in ankylosing spondylitis, psoriatic arthritis, and psoriasis","volume":"38","author":"Rosenberg","year":"1979","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0720","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/gut.33.5.668","article-title":"Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role","volume":"33","author":"Cambridge","year":"1992","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.autrev.2016.06.001_bb0725","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci","volume":"45","author":"International Genetics of Ankylosing Spondylitis C","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0730","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-3083.1991.tb01530.x","article-title":"Anti-granulocyte antibodies (C-ANCA, P-ANCA, GS-ANA) studied by confocal scanning laser fluorescence microscopy, ELISA, and chemiluminescence techniques","volume":"34","author":"Skogh","year":"1991","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2016.06.001_bb0735","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-4615-2548-6_14","article-title":"The role of lactoferrin as an anti-inflammatory molecule","volume":"357","author":"Britigan","year":"1994","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.autrev.2016.06.001_bb0740","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1046\/j.1365-2249.1999.01008.x","article-title":"Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis","volume":"117","author":"Locht","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2016.06.001_bb0745","first-page":"1891","article-title":"Prevalence of antiphospholipid antibodies in patients with ankylosing spondylitis","volume":"22","author":"Juanola","year":"1995","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0750","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"9957","key":"10.1016\/j.autrev.2016.06.001_bb0755","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","article-title":"Systemic lupus erythematosus","volume":"384","author":"Lisnevskaia","year":"2014","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0760","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.autrev.2015.08.011","article-title":"Delineating the deranged immune system in the antiphospholipid syndrome","volume":"15","author":"van den Hoogen","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"2\u20133","key":"10.1016\/j.autrev.2016.06.001_bb0765","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-5793(95)00760-7","article-title":"Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae","volume":"369","author":"Fielder","year":"1995","journal-title":"FEBS Lett"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0770","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3109\/03009749709065703","article-title":"Serum IgA1 and IgA2 subclass antibodies against collagens in patients with ankylosing spondylitis","volume":"26","author":"Tani","year":"1997","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2016.06.001_bb0775","first-page":"295","article-title":"Autoantibodies to collagens in Japanese patients with ankylosing spondylitis","volume":"15","author":"Tani","year":"1997","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2016.06.001_bb0780","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/rheumatology\/40.1.15","article-title":"Correlation between the immune responses to collagens type I, III, IV and V and Klebsiella pneumoniae in patients with Crohn's disease and ankylosing spondylitis","volume":"40","author":"Tiwana","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0785","first-page":"743","article-title":"Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis","volume":"25","author":"Blankenberg-Sprenkels","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.06.001_bb0790","series-title":"Autoantibodies","article-title":"Collagen autoantibodies","author":"Shen","year":"1996"},{"issue":"10","key":"10.1016\/j.autrev.2016.06.001_bb0795","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1136\/annrheumdis-2013-203630","article-title":"Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitis","volume":"73","author":"Tsui","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2016.06.001_bb0800","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M9.00384","article-title":"Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays","volume":"11","author":"Wright","year":"2012","journal-title":"Mol Cell Proteomics"},{"issue":"10","key":"10.1016\/j.autrev.2016.06.001_bb0805","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.38763","article-title":"Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis","volume":"66","author":"Kim","year":"2014","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0810","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/annrheumdis-2012-202208","article-title":"Autoantibodies against CD74 in spondyloarthritis","volume":"73","author":"Baerlecken","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0815","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/annrheumdis-2012-202177","article-title":"High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis","volume":"73","author":"Baraliakos","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0820","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.4049\/jimmunol.169.5.2772","article-title":"A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library","volume":"169","author":"Somers","year":"2002","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"6","key":"10.1016\/j.autrev.2016.06.001_bb0825","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.4049\/jimmunol.180.6.3957","article-title":"Autoantibody profiling in multiple sclerosis reveals novel antigenic candidates","volume":"180","author":"Somers","year":"2008","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"8","key":"10.1016\/j.autrev.2016.06.001_bb0830","first-page":"2979","article-title":"Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profiling","volume":"118","author":"Cleutjens","year":"2008","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.autrev.2016.06.001_bb0835","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/jnc.12005","article-title":"Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome","volume":"123","author":"Rouwette","year":"2012","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.autrev.2016.06.001_bb0840","first-page":"2147","article-title":"Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis","volume":"193","author":"de Bock","year":"2014","journal-title":"J Immunol (Baltimore, Mdaaa: 1950)"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216301197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216301197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T16:35:46Z","timestamp":1568046946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216301197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":168,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1568997216301197"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.06.001","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of novel diagnostic antibodies in ankylosing spondylitis: An overview","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}